Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician in the frame of a study and described the occurrence of intussusception in a 5-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included live attenuated human rotavirus vaccine (GlaxoSmithKline, oral) given on 22 February 2008; pneumococcal vaccine, unspecified (manufacturer unspecified, intramuscular) given on 3 April 2008. On 3 April 2008 the subject received 2nd dose of ROTARIX (oral). On 4 April 2008, 1 day after vaccination with ROTARIX, the subject presented upper respiratory tract infection not specified and characterised by fever, vomiting and not oral acceptance. The subject was treated with Paracetamol and Ampicillin without improvement. On 7 April 2008, the subject continued with vomiting and fever. On 10 April 2008 the subject was brought to the emergency room with persisting fever, vomiting and mucosanguinolent stool. at physical examination he showed dehydration, malaise, pallor, pharyngeal hyperemia, abdominal pain timpanic and distended, absent bowel sound and rectal tract with evidence of current jelly stools. Relevant test results included abdominal x-ray which showed suggestive image of intussusception, dilated small bowel and lack of air in distal colon. Therefore the same day the subject underwent a surgery. Ileocecal intussusception was found without complications in intestinal loops, only reduction by taxis was done. After that the subject''s clinical condition was favorable. On 15 April 2008 the subject was discharged. The physician considered the events were possibly related to vaccination with ROTARIX.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166